产品: | PTK6 抗体 |
货号: | BF0203 |
描述: | Mouse monoclonal antibody to PTK6 |
应用: | WB ELISA |
反应: | Human |
分子量: | 52kDa; 52kD(Calculated). |
蛋白号: | Q13882 |
RRID: | AB_2833592 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# BF0203, RRID:AB_2833592.
展开/折叠
Breast tumor kinase; Breast tumour kinase; Protein tyrosine kinase 6; Protein-tyrosine kinase 6; Ptk6; PTK6_HUMAN; Tyrosine protein kinase BRK; Tyrosine-protein kinase BRK;
抗原和靶标
Purified recombinant fragment of human PTK6 expressed in E. Coli.
Epithelia-specific. Very high level in colon and high levels in small intestine and prostate, and low levels in some fetal tissues. Not expressed in breast or ovarian tissue but expressed in high percentage of breast and ovarian cancers. Also overexpressed in some metastatic melanomas, lymphomas, colon cancers, squamous cell carcinomas and prostate cancers. Also found in melanocytes. Not expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Isoform 2 is present in prostate epithelial cell lines derived from normal prostate and prostate adenocarcinomas, as well as in a variety of cell lines.
- Q13882 PTK6_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQGYVPHNYLAERETVESEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYHRAQSLSHGLRLAAPCRKHEPEPLPHWDDWERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSSFTSYENPT
翻译修饰 - Q13882 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y13 | Phosphorylation | Q13882 (PTK6) | Uniprot |
Y61 | Phosphorylation | Q13882 (PTK6) | Uniprot |
Y66 | Phosphorylation | Q13882 (PTK6) | Uniprot |
S111 | Phosphorylation | Uniprot | |
Y114 | Phosphorylation | Q13882 (PTK6) | Uniprot |
S117 | Phosphorylation | Uniprot | |
Y127 | Phosphorylation | Uniprot | |
S159 | Phosphorylation | Uniprot | |
S279 | Phosphorylation | Uniprot | |
Y342 | Phosphorylation | Q13882 (PTK6) | Uniprot |
S344 | Phosphorylation | Uniprot | |
Y351 | Phosphorylation | Q13882 (PTK6) | Uniprot |
K352 | Ubiquitination | Uniprot | |
T445 | Phosphorylation | Uniprot | |
S446 | Phosphorylation | Uniprot | |
Y447 | Phosphorylation | Q13882 (PTK6) , Q9H3Y6 (SRMS) | Uniprot |
翻译修饰 - Q13882 作为激酶
Substrate | Site | Source |
---|---|---|
P00533 (EGFR) | Y869 | Uniprot |
P31749 (AKT1) | Y315 | Uniprot |
P31749 (AKT1) | Y326 | Uniprot |
P35222 (CTNNB1) | Y64 | Uniprot |
P35222 (CTNNB1) | Y142 | Uniprot |
P35222 (CTNNB1) | Y331 | Uniprot |
P35222 (CTNNB1) | Y333 | Uniprot |
P40763 (STAT3) | Y705 | Uniprot |
P42229 (STAT5A) | Y694 | Uniprot |
P49023-2 (PXN) | Y31 | Uniprot |
P49023-2 (PXN) | Y118 | Uniprot |
P51692 (STAT5B) | Y699 | Uniprot |
P56945 (BCAR1) | Y165 | Uniprot |
P56945 (BCAR1) | Y224 | Uniprot |
P56945 (BCAR1) | Y234 | Uniprot |
P56945 (BCAR1) | Y249 | Uniprot |
P56945 (BCAR1) | Y262 | Uniprot |
P56945 (BCAR1) | Y267 | Uniprot |
P56945 (BCAR1) | Y287 | Uniprot |
P56945 (BCAR1) | Y306 | Uniprot |
P56945 (BCAR1) | Y327 | Uniprot |
P56945 (BCAR1) | Y362 | Uniprot |
P56945 (BCAR1) | Y387 | Uniprot |
P56945 (BCAR1) | Y664 | Uniprot |
Q05397 (PTK2) | Y861 | Uniprot |
Q07666 (KHDRBS1) | Y435 | Uniprot |
Q07666 (KHDRBS1) | Y440 | Uniprot |
Q07666-1 (KHDRBS1) | Y443 | Uniprot |
Q13017 (ARHGAP5) | Y1109 | Uniprot |
Q13882 (PTK6) | Y13 | Uniprot |
Q13882 (PTK6) | Y61 | Uniprot |
Q13882 (PTK6) | Y66 | Uniprot |
Q13882 (PTK6) | Y114 | Uniprot |
Q13882-1 (PTK6) | Y342 | Uniprot |
Q13882 (PTK6) | Y351 | Uniprot |
Q13882 (PTK6) | Y447 | Uniprot |
Q96P48 (ARAP1) | Y231 | Uniprot |
Q99704 (DOK1) | Y362 | Uniprot |
Q9NRY4 (ARHGAP35) | Y1105 | Uniprot |
Q9UGK3 (STAP2) | Y250 | Uniprot |
研究背景
Non-receptor tyrosine-protein kinase implicated in the regulation of a variety of signaling pathways that control the differentiation and maintenance of normal epithelia, as well as tumor growth. Function seems to be context dependent and differ depending on cell type, as well as its intracellular localization. A number of potential nuclear and cytoplasmic substrates have been identified. These include the RNA-binding proteins: KHDRBS1/SAM68, KHDRBS2/SLM1, KHDRBS3/SLM2 and SFPQ/PSF; transcription factors: STAT3 and STAT5A/B and a variety of signaling molecules: ARHGAP35/p190RhoGAP, PXN/paxillin, BTK/ATK, STAP2/BKS. Associates also with a variety of proteins that are likely upstream of PTK6 in various signaling pathways, or for which PTK6 may play an adapter-like role. These proteins include ADAM15, EGFR, ERBB2, ERBB3 and IRS4. In normal or non-tumorigenic tissues, PTK6 promotes cellular differentiation and apoptosis. In tumors PTK6 contributes to cancer progression by sensitizing cells to mitogenic signals and enhancing proliferation, anchorage-independent survival and migration/invasion. Association with EGFR, ERBB2, ERBB3 may contribute to mammary tumor development and growth through enhancement of EGF-induced signaling via BTK/AKT and PI3 kinase. Contributes to migration and proliferation by contributing to EGF-mediated phosphorylation of ARHGAP35/p190RhoGAP, which promotes association with RASA1/p120RasGAP, inactivating RhoA while activating RAS. EGF stimulation resulted in phosphorylation of PNX/Paxillin by PTK6 and activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. PTK6 activates STAT3 and STAT5B to promote proliferation. Nuclear PTK6 may be important for regulating growth in normal epithelia, while cytoplasmic PTK6 might activate oncogenic signaling pathways.
Isoform 2 inhibits PTK6 phosphorylation and PTK6 association with other tyrosine-phosphorylated proteins.
Autophosphorylated. Autophosphorylation of Tyr-342 leads to an increase of kinase activity. Tyr-447 binds to the SH2 domain when phosphorylated and negatively regulates kinase activity.
Cytoplasm. Nucleus. Cell projection>Ruffle. Membrane.
Note: Colocalizes with KHDRBS1, KHDRBS2 or KHDRBS3, within the nucleus. Nuclear localization in epithelial cells of normal prostate but cytoplasmic localization in cancer prostate.
Epithelia-specific. Very high level in colon and high levels in small intestine and prostate, and low levels in some fetal tissues. Not expressed in breast or ovarian tissue but expressed in high percentage of breast and ovarian cancers. Also overexpressed in some metastatic melanomas, lymphomas, colon cancers, squamous cell carcinomas and prostate cancers. Also found in melanocytes. Not expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Isoform 2 is present in prostate epithelial cell lines derived from normal prostate and prostate adenocarcinomas, as well as in a variety of cell lines.
Interacts with GAP-A.p65 (By similarity). Interacts (via SH3 and SH2 domains) with KHDRBS1. Interacts (via SH3 and SH2 domains) with phosphorylated IRS4. Interacts with ADAM15. Interacts (via SH3 domain) with SFPQ. Interacts with EGFR and ERBB2. Interacts with STAP2. Interacts with PNX. Interacts with SFPQ. Interacts with PTK/ATK. Interacts with CTNNB1.
The SH3 domain plays a major role in substrate interactions. The SH2 domain of PTK6 plays a role in protein-protein interactions, but is likely more important for the regulation of catalytic activity.
Belongs to the protein kinase superfamily. Tyr protein kinase family. BRK/PTK6/SIK subfamily.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.